The time to act is now: that was the collective feeling at the 2015 Face-to-Face Drug Plan Management conference on Dec. 2 in Toronto. As plan sponsors grapple with an influx of costly new drugs, employee non-compliance issues and a lack of case management, panellists at the conference brainstormed for the best ways to help employers maintain the sustainability of their benefits plans and help sponsors.
Here are some of the highlights of the sessions.
Photos from the event can be found in our photo gallery.
The new rules of engagement
What employer doesn’t want more engaged employees and cost savings on their benefit plans? At the Face-to-Face Drug Plan Management Conference in Toronto on Dec. 2, John Law, global director, benefits, and director, total rewards, Canada and Latin Americas for Pitney Bowes Inc., told his company’s experience with revamping its benefits plan.
Benefits Canada’s big reveal: Experts weigh in on new drug trend data
Are plan sponsors aware of the benefits plan challenges they face? Yes and no, according to Benefits Canada’s 2015 online survey of 204 senior benefit decision-makers. The survey revealed that an alarming number of sponsors are unaware of the state of their plans.
Sharing the benefits burden
Employers are divided when it comes to drugs. On the one hand, 90% of participants in Benefits Canada’s 2015 online survey strongly or somewhat agree that it would be worth it to pay for a high-cost drug if it meant their employee continued to be healthy and productive. On the other hand, they want financial help in providing all of that largesse.